Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...

This is Allison’s personal multiple myeloma story, and others may be different. Allison is a paid spokesperson for GSK.

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...